srch

Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern ... Become an Executive Guest Editor.

He assumed his present position as Editor, Drug Discovery Today, at Elsevier in 2002. Previously a visiting Professor of Biochemistry at the University of North Carolina, Chapel Hill, he currently holds an honorary lectureship in Drug Discovery at the University of Surrey, UK. He has authored over 50 articles in peer-reviewed journals and ...

Drug Discovery Today ENews - July 2021. Editor's Choice. The Current issue of “The view from here” is concerned with Artificial Intelligence Please join us at the Zoom launch event for Elsevier’s new journal: “Artificial Intelligence in the Life Sciences” Wednesday May …

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how …

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection.

Drug Discovery Today is a monthly peer-reviewed scientific journal that is published by Elsevier. It was established in 1996 and publishes reviews on all ...

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how …. Read more

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, …

Rm 3-150, 3/F, China Merchants Plaza, 333 North Chengdu Road, Jingan District, Shanghai, China, 200041

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection.

Contacts. Dr. Steve Carney Editor Tel: +44 (0) 330 161 2931. Fax ...

Pathophysiology models for drug discovery. Dimitrios Zeugolis September 2016 Volume 21, Issue 9. SI: Precision medicine. December 2015 Volume 20, Issue 12. Theme sections: * Huntington's Disease. Guest Editor: Craig Blackstone * Exercise Physiology. Guest Editor: Pontus Almer Bostrom. July 2014 Volume 19, Issue 7. Tissue therapeutics and ...

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, …

Photo of Jürgen Bajorath. Jürgen Bajorath · Photo of David Brayden. David Brayden · Paul Caron. Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, United ...

Drug Discovery Today Review Speed, Peer-Review Duration, Revision Process, Time from Submission to 1st Editorial/Reviewer Decision & Time from Submission to ...

Read the latest articles of Drug Discovery Today at ScienceDirect.com, Elsevier's leading platform of peer-reviewed scholarly literature.

Thomas Fuchss (LinkedIn: Thomas Fuchß, Twitter: @Fuchss_Thomas) is Director in Global Medicinal Chemistry at Merck KGaA, Darmstadt, Germany. Thomas received his diploma in Chemistry and doctorate with honors from Universität Konstanz, Germany on the synthesis of functionalized carbon and sulfur glycosides of nojirimycin and N-acetyl glucosamine including glycoside hydrolase inhibitors and C ...

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Nature Reviews Drug Discovery is a journal for people interested in drug discovery and development. It features reviews, news, analysis and research ...

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, …

Essential Science Indicators Field · Published by · Review policy on Publons · Reviews · Interested in reviewing for this journal? · Editorial board members on ...

He assumed his present position as Editor, Drug Discovery Today, at Elsevier in 2002. Previously a visiting Professor of Biochemistry at the University of North Carolina, Chapel Hill, he currently holds an honorary lectureship in Drug Discovery at the University of Surrey, UK. He has authored over 50 articles in peer-reviewed journals and ...

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, …

Drug Discovery Today: Technologies Editors-in-Chief: Kelvin Lam and Henk Timmerman Drug Discovery Today: Technologies systematically review of the latest technologies and methods as well as improvements to established ones, that are relevant to drug discovery and development: from expression systems, to high-throughput technologies, to detailed bioinformatics and …